Bacteriophages : Alternatives to Antibiotics and Beyond
There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacter...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (390 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993546336004498 |
---|---|
ctrlnum |
(CKB)5400000000045038 (oapen)https://directory.doabooks.org/handle/20.500.12854/69333 (EXLCZ)995400000000045038 |
collection |
bib_alma |
record_format |
marc |
spelling |
Suárez, Pilar García edt Bacteriophages Alternatives to Antibiotics and Beyond Bacteriophages Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (390 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacterial infections than from cancer. While we are still learning all the subtle drivers of antibiotic resistance, it seems increasingly clear that we need to take a “one health” approach, curtailing the use of antibiotics in both human and veterinary medicine. However, there are no new classes of antibiotics on our horizon. Maybe something that has been around “forever” can come to our rescue—bacteriophages! Nevertheless, it is also necessary to do things differently, and use these new antimicrobials appropriately. Therefore, an in-depth study of bacteriophage biology and case-by-case applications might be required. Whilst by no means comprehensive, this book does cover some of the many topics related to bacteriophages as antimicrobials, including their use in human therapy and aquaculture. It also explores the potential use of phage endolysins as substitutes of antibiotics in two sectors where there is an urgent need—human therapy and the agro-food industry. Last but not least, there is an excellent perspective article on phage therapy implementation. English Medicine bicssc bacteriophages dairy industry pathogens lactic acid bacteria fermentation failure biofilms antimicrobial resistance antimicrobials lysins horizontal gene transfer, transduction biofilm phage therapy resistance bacteriophage models agent based mass action bacterial phage resistance regression modeling MRSA Clostridium difficile Clostridium difficile infection microbiome in vitro fermentation model marine vibrios biological control aquaculture interactions vibriosis Aeromonas hydrophila Motile Aeromonas Septicemia MAS multiple-antibiotic-resistance striped catfish (Pangasianodon hypophthalmus) endolysin antibiotics one health protein engineering Aeromonas salmonicida furunculosis phage-resistant mutants proteins infrared spectroscopy lysin lytic enzyme peptidoglycan hydrolase antimicrobial antibacterial antibiotic resistance bacteriophage therapy Nagoya Protocol CRISPR CAS phage isolation phage resistance Staphylococcus Kayvirus Vibrio anguillarum fish larvae challenge trials phage display enzybiotics diabetic foot ulcer osteomyelitis Staphylococcus aureus Antibiotic-resistant bacteria lysogenic conversion prophage induction read recruitment shiga toxin American Foulbrood phage Paenibacillus larvae Brevibacillus laterosporus treatment safety bystander phage therapy Mycobacterium smegmatis mycobacteriophages directed evolution PlyC CHAP protein net charge CBD-independent FoldX STEC-specific bacteriophage whole genome sequencing STEC O145 strains antimicrobial agent Pseudomonas aeruginosa dual-species antibiotic synergy simultaneous sequential microbiome therapy evolution 3-03943-404-7 3-03943-405-5 Fernández, Lucía edt Suárez, Pilar García oth Fernández, Lucía oth |
language |
English |
format |
eBook |
author2 |
Fernández, Lucía Suárez, Pilar García Fernández, Lucía |
author_facet |
Fernández, Lucía Suárez, Pilar García Fernández, Lucía |
author2_variant |
p g s pg pgs l f lf |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Bacteriophages Alternatives to Antibiotics and Beyond |
spellingShingle |
Bacteriophages Alternatives to Antibiotics and Beyond |
title_sub |
Alternatives to Antibiotics and Beyond |
title_full |
Bacteriophages Alternatives to Antibiotics and Beyond |
title_fullStr |
Bacteriophages Alternatives to Antibiotics and Beyond |
title_full_unstemmed |
Bacteriophages Alternatives to Antibiotics and Beyond |
title_auth |
Bacteriophages Alternatives to Antibiotics and Beyond |
title_alt |
Bacteriophages |
title_new |
Bacteriophages |
title_sort |
bacteriophages alternatives to antibiotics and beyond |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (390 p.) |
isbn |
3-03943-404-7 3-03943-405-5 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT suarezpilargarcia bacteriophagesalternativestoantibioticsandbeyond AT fernandezlucia bacteriophagesalternativestoantibioticsandbeyond AT suarezpilargarcia bacteriophages AT fernandezlucia bacteriophages |
status_str |
n |
ids_txt_mv |
(CKB)5400000000045038 (oapen)https://directory.doabooks.org/handle/20.500.12854/69333 (EXLCZ)995400000000045038 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Bacteriophages Alternatives to Antibiotics and Beyond |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1796648777885417472 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05600nam-a2201477z--4500</leader><controlfield tag="001">993546336004498</controlfield><controlfield tag="005">20240122104458.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000045038</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69333</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000045038</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Suárez, Pilar García</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bacteriophages</subfield><subfield code="b">Alternatives to Antibiotics and Beyond</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Bacteriophages</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (390 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacterial infections than from cancer. While we are still learning all the subtle drivers of antibiotic resistance, it seems increasingly clear that we need to take a “one health” approach, curtailing the use of antibiotics in both human and veterinary medicine. However, there are no new classes of antibiotics on our horizon. Maybe something that has been around “forever” can come to our rescue—bacteriophages! Nevertheless, it is also necessary to do things differently, and use these new antimicrobials appropriately. Therefore, an in-depth study of bacteriophage biology and case-by-case applications might be required. Whilst by no means comprehensive, this book does cover some of the many topics related to bacteriophages as antimicrobials, including their use in human therapy and aquaculture. It also explores the potential use of phage endolysins as substitutes of antibiotics in two sectors where there is an urgent need—human therapy and the agro-food industry. Last but not least, there is an excellent perspective article on phage therapy implementation.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteriophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dairy industry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathogens</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lactic acid bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fermentation failure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biofilms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">horizontal gene transfer, transduction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biofilm</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteriophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">models</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">agent based</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mass action</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacterial phage resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">regression modeling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MRSA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Clostridium difficile</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Clostridium difficile infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microbiome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro fermentation model</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marine vibrios</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biological control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aquaculture</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interactions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vibriosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Aeromonas hydrophila</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Motile Aeromonas Septicemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MAS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiple-antibiotic-resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">striped catfish (Pangasianodon hypophthalmus)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endolysin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">one health</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein engineering</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Aeromonas salmonicida</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">furunculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage-resistant mutants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infrared spectroscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lytic enzyme</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptidoglycan hydrolase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteriophage therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Nagoya Protocol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CRISPR CAS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage isolation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Staphylococcus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Kayvirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Vibrio anguillarum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fish larvae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">challenge trials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage display</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">enzybiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Bacteriophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetic foot ulcer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">osteomyelitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Staphylococcus aureus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Antibiotic-resistant bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysogenic conversion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prophage induction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">read recruitment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">shiga toxin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">American Foulbrood</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Paenibacillus larvae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Brevibacillus laterosporus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">safety</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bystander phage therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mycobacterium smegmatis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mycobacteriophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">directed evolution</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PlyC CHAP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein net charge</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CBD-independent</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FoldX</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STEC-specific bacteriophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">whole genome sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STEC O145 strains</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial agent</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pseudomonas aeruginosa</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dual-species</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">synergy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">simultaneous</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sequential</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microbiome therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">evolution</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-404-7</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-405-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fernández, Lucía</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suárez, Pilar García</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fernández, Lucía</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-01-23 00:50:11 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338233260004498&Force_direct=true</subfield><subfield code="Z">5338233260004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338233260004498</subfield></datafield></record></collection> |